Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
33
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Tsai John | Director | 12 | $0 | $0 | 2025-07-17 |
| Carter Percy H. | Chief Scientific Officer | 30 | $0 | $1.94M | 2025-07-17 |
| Lee Philina | Chief Commercial Officer | 39 | $0 | $5.31M | 2025-07-17 |
| Hewes L. Becker | Chief Medical Officer | 59 | $0 | $7.70M | 2025-07-17 |
| Namouni Fouad | President, R & D | 30 | $0 | $2.18M | 2025-07-17 |
| Durso-Bumpus Debra | Chief People Officer | 76 | $0 | $12.14M | 2025-07-17 |
| Hurley Ariel | Principal Accounting Officer | 166 | $0 | $5.50M | 2025-07-17 |
| Rossi Christina | Chief Operating Officer | 59 | $0 | $3.37M | 2025-07-17 |
| Dable Habib J | Director | 12 | $0 | $0 | 2025-07-17 |
| McCain Tracey L | EVP and Chief Legal Officer | 58 | $0 | $6.09M | 2025-07-17 |
| Haviland Kate | Chief Operating Officer | 161 | $48.4K | $13.63M | 2025-07-17 |
| Landsittel Michael | PFO and PAO | 59 | $0 | $4.91M | 2025-07-17 |
| Albers Jeffrey W. | Director | 303 | $0 | $62.43M | 2025-07-17 |
| COATS LONNEL | Director | 42 | $0 | $2.69M | 2025-07-17 |
| Goldberg Mark Alan | Director | 47 | $299.9K | $3.68M | 2025-07-17 |
| Beckman Daniella | Director | 15 | $0 | $0 | 2025-07-17 |
| Seely Lynn | Director | 31 | $0 | $0 | 2025-07-17 |
| Borisy Alexis | Director | 40 | $0 | $2.01M | 2025-07-17 |
| Lydon Nicholas | Director | 43 | $0 | $13.83M | 2024-06-12 |
| Murray Christopher K. | SVP, Technical Operations | 32 | $0 | $1.86M | 2024-03-07 |
| Demetri George | Director | 29 | $827 | $1.68M | 2022-06-21 |
| Tango Therapeutics, Inc. | Director | 2 | $0 | $0 | 2021-12-08 |
| Rowland Charles A Jr | Director | 27 | $0 | $3.40M | 2021-06-02 |
| Dorsch Marion | Chief Scientific Officer | 56 | $0 | $5.90M | 2021-02-22 |
| Boral Anthony L. | Chief Medical Officer | 59 | $0 | $7.23M | 2020-12-14 |
| LYNCH DANIEL | Director | 29 | $0 | $5.84M | 2020-06-24 |
| LEVIN MARK J | 10% Owner | 3 | $0 | $1.23M | 2017-03-16 |
| TEPPER ROBERT I | 10% Owner | 2 | $0 | $35.28M | 2017-02-27 |
| STARR KEVIN P | 10% Owner | 1 | $0 | $3.00M | 2016-12-19 |
| Lengauer Christoph | Chief Scientific Officer | 13 | $0 | $3.27M | 2016-04-13 |
| FMR LLC | Other | 34 | $2.25M | $19.09M | 2015-11-27 |
| TRV GP II, LLC | 10% Owner | 6 | $0 | $0 | 2015-11-18 |
| Third Rock Ventures II, L.P. | 10% Owner | 6 | $0 | $0 | 2015-05-05 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Albers Jeffrey W. | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 90,000 | — | $0 | 0 | SEC↗ |
| Albers Jeffrey W. | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 5,300 | — | $0 | 0 | SEC↗ |
| Albers Jeffrey W. | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 15,000 | — | $0 | 0 | SEC↗ |
| Albers Jeffrey W. | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 80,000 | — | $0 | 0 | SEC↗ |
| Albers Jeffrey W. | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 4,570 | — | $0 | 0 | SEC↗ |
| Albers Jeffrey W. | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 110,500 | — | $0 | 0 | SEC↗ |
| Albers Jeffrey W. | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 170,000 | — | $0 | 0 | SEC↗ |
| Albers Jeffrey W. | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 92,500 | — | $0 | 0 | SEC↗ |
| Lee Philina | Chief Commercial Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 20,669 | — | $0 | 0 | SEC↗ |
| Lee Philina | Chief Commercial Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 8,650 | — | $0 | 0 | SEC↗ |
| Lee Philina | Chief Commercial Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 6,928 | — | $0 | 0 | SEC↗ |
| Lee Philina | Chief Commercial Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 25,000 | — | $0 | 0 | SEC↗ |
| Lee Philina | Chief Commercial Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 22,000 | — | $0 | 0 | SEC↗ |
| Durso-Bumpus Debra | Chief People Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 25,000 | — | $0 | 0 | SEC↗ |
| Durso-Bumpus Debra | Chief People Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 26,125 | — | $0 | 0 | SEC↗ |
| Durso-Bumpus Debra | Chief People Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 25,000 | — | $0 | 0 | SEC↗ |
| Durso-Bumpus Debra | Chief People Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 25,000 | — | $0 | 0 | SEC↗ |
| Durso-Bumpus Debra | Chief People Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 22,000 | — | $0 | 0 | SEC↗ |
| Durso-Bumpus Debra | Chief People Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 15,367 | — | $0 | 0 | SEC↗ |
| Durso-Bumpus Debra | Chief People Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 30,500 | — | $0 | 0 | SEC↗ |
| Durso-Bumpus Debra | Chief People Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 21,125 | — | $0 | 0 | SEC↗ |
| McCain Tracey L | EVP & Chief Legal Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 28,500 | — | $0 | 0 | SEC↗ |
| McCain Tracey L | EVP & Chief Legal Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 25,000 | — | $0 | 0 | SEC↗ |
| McCain Tracey L | EVP & Chief Legal Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 25,000 | — | $0 | 0 | SEC↗ |
| McCain Tracey L | EVP & Chief Legal Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 25,000 | — | $0 | 0 | SEC↗ |
| McCain Tracey L | EVP & Chief Legal Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 26,125 | — | $0 | 0 | SEC↗ |
| McCain Tracey L | EVP & Chief Legal Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 29,900 | — | $0 | 0 | SEC↗ |
| McCain Tracey L | EVP & Chief Legal Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 22,000 | — | $0 | 0 | SEC↗ |
| McCain Tracey L | EVP & Chief Legal Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 55,000 | — | $0 | 0 | SEC↗ |
| McCain Tracey L | EVP & Chief Legal Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 5,000 | — | $0 | 0 | SEC↗ |
| McCain Tracey L | EVP & Chief Legal Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 39,000 | — | $0 | 0 | SEC↗ |
| Beckman Daniella | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 5,300 | — | $0 | 0 | SEC↗ |
| Beckman Daniella | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 7,000 | — | $0 | 0 | SEC↗ |
| Beckman Daniella | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 5,300 | — | $0 | 0 | SEC↗ |
| Beckman Daniella | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 4,570 | — | $0 | 0 | SEC↗ |
| Namouni Fouad | PRESIDENT, R & D | D To issuer deriv | 2025-07-17 | 2025-07-21 | 30,000 | — | $0 | 0 | SEC↗ |
| Namouni Fouad | PRESIDENT, R & D | D To issuer deriv | 2025-07-17 | 2025-07-21 | 30,000 | — | $0 | 0 | SEC↗ |
| Namouni Fouad | PRESIDENT, R & D | D To issuer deriv | 2025-07-17 | 2025-07-21 | 26,400 | — | $0 | 0 | SEC↗ |
| Namouni Fouad | PRESIDENT, R & D | D To issuer deriv | 2025-07-17 | 2025-07-21 | 30,000 | — | $0 | 0 | SEC↗ |
| Namouni Fouad | PRESIDENT, R & D | D To issuer deriv | 2025-07-17 | 2025-07-21 | 26,125 | — | $0 | 0 | SEC↗ |
| Namouni Fouad | PRESIDENT, R & D | D To issuer deriv | 2025-07-17 | 2025-07-21 | 65,000 | — | $0 | 0 | SEC↗ |
| Goldberg Mark Alan | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 7,500 | — | $0 | 0 | SEC↗ |
| Goldberg Mark Alan | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 10,909 | — | $0 | 0 | SEC↗ |
| Goldberg Mark Alan | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 4,875 | — | $0 | 0 | SEC↗ |
| Goldberg Mark Alan | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 4,500 | — | $0 | 0 | SEC↗ |
| Goldberg Mark Alan | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 4,500 | — | $0 | 0 | SEC↗ |
| Goldberg Mark Alan | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 5,300 | — | $0 | 0 | SEC↗ |
| Goldberg Mark Alan | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 5,300 | — | $0 | 0 | SEC↗ |
| Goldberg Mark Alan | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 4,570 | — | $0 | 0 | SEC↗ |
| Borisy Alexis | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 4,570 | — | $0 | 0 | SEC↗ |
| Borisy Alexis | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 7,500 | — | $0 | 0 | SEC↗ |
| Borisy Alexis | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 4,875 | — | $0 | 0 | SEC↗ |
| Borisy Alexis | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 4,500 | — | $0 | 0 | SEC↗ |
| Borisy Alexis | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 4,500 | — | $0 | 0 | SEC↗ |
| Borisy Alexis | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 5,300 | — | $0 | 0 | SEC↗ |
| Borisy Alexis | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 5,300 | — | $0 | 0 | SEC↗ |
| Haviland Kate | Chief Executive Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 28,500 | — | $0 | 0 | SEC↗ |
| Haviland Kate | Chief Executive Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 80,000 | — | $0 | 0 | SEC↗ |
| Haviland Kate | Chief Executive Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 80,000 | — | $0 | 0 | SEC↗ |
| Haviland Kate | Chief Executive Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 80,000 | — | $0 | 0 | SEC↗ |
| Haviland Kate | Chief Executive Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 26,125 | — | $0 | 0 | SEC↗ |
| Haviland Kate | Chief Executive Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 70,400 | — | $0 | 0 | SEC↗ |
| Haviland Kate | Chief Executive Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 32,500 | — | $0 | 0 | SEC↗ |
| Haviland Kate | Chief Executive Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 39,000 | — | $0 | 0 | SEC↗ |
| Haviland Kate | Chief Executive Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 591 | — | $0 | 0 | SEC↗ |
| Haviland Kate | Chief Executive Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 2 | — | $0 | 0 | SEC↗ |
| Rossi Christina | Chief Operating Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 26,125 | — | $0 | 0 | SEC↗ |
| Rossi Christina | Chief Operating Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 28,500 | — | $0 | 0 | SEC↗ |
| Rossi Christina | Chief Operating Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 6,500 | — | $0 | 0 | SEC↗ |
| Rossi Christina | Chief Operating Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 80,000 | — | $0 | 0 | SEC↗ |
| Rossi Christina | Chief Operating Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 26,400 | — | $0 | 0 | SEC↗ |
| Rossi Christina | Chief Operating Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 30,000 | — | $0 | 0 | SEC↗ |
| Rossi Christina | Chief Operating Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 30,000 | — | $0 | 0 | SEC↗ |
| Rossi Christina | Chief Operating Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 30,000 | — | $0 | 0 | SEC↗ |
| Carter Percy H. | Chief Scientific Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 17,500 | — | $0 | 0 | SEC↗ |
| Carter Percy H. | Chief Scientific Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 25,000 | — | $0 | 0 | SEC↗ |
| Carter Percy H. | Chief Scientific Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 25,000 | — | $0 | 0 | SEC↗ |
| Carter Percy H. | Chief Scientific Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 22,000 | — | $0 | 0 | SEC↗ |
| Carter Percy H. | Chief Scientific Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 39,200 | — | $0 | 0 | SEC↗ |
| Seely Lynn | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 4,875 | — | $0 | 0 | SEC↗ |
| Seely Lynn | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 7,500 | — | $0 | 0 | SEC↗ |
| Seely Lynn | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 4,570 | — | $0 | 0 | SEC↗ |
| Seely Lynn | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 10,909 | — | $0 | 0 | SEC↗ |
| Seely Lynn | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 21,818 | — | $0 | 0 | SEC↗ |
| Seely Lynn | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 4,500 | — | $0 | 0 | SEC↗ |
| Seely Lynn | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 4,500 | — | $0 | 0 | SEC↗ |
| Seely Lynn | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 5,300 | — | $0 | 0 | SEC↗ |
| Seely Lynn | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 5,300 | — | $0 | 0 | SEC↗ |
| Seely Lynn | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 10,909 | — | $0 | 0 | SEC↗ |
| Hewes L. Becker | Chief Medical Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 9,115 | — | $0 | 0 | SEC↗ |
| Hewes L. Becker | Chief Medical Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 26,125 | — | $0 | 0 | SEC↗ |
| Hewes L. Becker | Chief Medical Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 13,490 | — | $0 | 0 | SEC↗ |
| Hewes L. Becker | Chief Medical Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 22,000 | — | $0 | 0 | SEC↗ |
| Hewes L. Becker | Chief Medical Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 25,000 | — | $0 | 0 | SEC↗ |
| Hewes L. Becker | Chief Medical Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 19,271 | — | $0 | 0 | SEC↗ |
| COATS LONNEL | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 4,500 | — | $0 | 0 | SEC↗ |
| COATS LONNEL | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 3,188 | — | $0 | 0 | SEC↗ |
| COATS LONNEL | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 4,875 | — | $0 | 0 | SEC↗ |
| COATS LONNEL | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 10,909 | — | $0 | 0 | SEC↗ |
| COATS LONNEL | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 10,909 | — | $0 | 0 | SEC↗ |
| COATS LONNEL | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 11,818 | — | $0 | 0 | SEC↗ |
| COATS LONNEL | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 5,300 | — | $0 | 0 | SEC↗ |
| COATS LONNEL | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 4,570 | — | $0 | 0 | SEC↗ |
| COATS LONNEL | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 5,300 | — | $0 | 0 | SEC↗ |
| Tsai John | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 7,950 | — | $0 | 0 | SEC↗ |
| Tsai John | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 5,300 | — | $0 | 0 | SEC↗ |
| Tsai John | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 4,570 | — | $0 | 0 | SEC↗ |
| Hurley Ariel | Principal Accounting Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 10,000 | — | $0 | 0 | SEC↗ |
| Hurley Ariel | Principal Accounting Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 6,375 | — | $0 | 0 | SEC↗ |
| Hurley Ariel | Principal Accounting Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 5,750 | — | $0 | 0 | SEC↗ |
| Hurley Ariel | Principal Accounting Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 9,494 | — | $0 | 0 | SEC↗ |
| Hurley Ariel | Principal Accounting Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 2,751 | — | $0 | 0 | SEC↗ |
| Hurley Ariel | Principal Accounting Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 7,007 | — | $0 | 0 | SEC↗ |
| Hurley Ariel | Principal Accounting Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 11,399 | — | $0 | 0 | SEC↗ |
| Hurley Ariel | Principal Accounting Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 12,000 | — | $0 | 0 | SEC↗ |
| Hurley Ariel | Principal Accounting Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 2,250 | — | $0 | 0 | SEC↗ |
| Dable Habib J | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 5,300 | — | $0 | 0 | SEC↗ |
| Dable Habib J | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 4,570 | — | $0 | 0 | SEC↗ |
| Dable Habib J | Director | D To issuer deriv | 2025-07-17 | 2025-07-21 | 7,950 | — | $0 | 0 | SEC↗ |
| Landsittel Michael | Chief Financial Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 25,000 | — | $0 | 0 | SEC↗ |
| Landsittel Michael | Chief Financial Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 26,125 | — | $0 | 0 | SEC↗ |
| Landsittel Michael | Chief Financial Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 25,000 | — | $0 | 0 | SEC↗ |
| Landsittel Michael | Chief Financial Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 19,500 | — | $0 | 0 | SEC↗ |
| Landsittel Michael | Chief Financial Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 26,000 | — | $0 | 0 | SEC↗ |
| Landsittel Michael | Chief Financial Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 10,000 | — | $0 | 0 | SEC↗ |
| Landsittel Michael | Chief Financial Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 25,000 | — | $0 | 0 | SEC↗ |
| Landsittel Michael | Chief Financial Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 22,000 | — | $0 | 0 | SEC↗ |
| Landsittel Michael | Chief Financial Officer | D To issuer deriv | 2025-07-17 | 2025-07-21 | 25,000 | — | $0 | 0 | SEC↗ |
| Albers Jeffrey W. | Director | D To issuer | 2025-07-17 | 2025-07-21 | 5,777 | — | $0 | 144,755 | SEC↗ |
| Albers Jeffrey W. | Director | U Tender | 2025-07-17 | 2025-07-21 | 144,755 | — | $0 | 0 | SEC↗ |
| Lee Philina | Chief Commercial Officer | U Tender | 2025-07-17 | 2025-07-21 | 13,184 | — | $0 | 0 | SEC↗ |
| Lee Philina | Chief Commercial Officer | A Award | 2025-07-17 | 2025-07-21 | 21,353 | — | $0 | 63,349 | SEC↗ |
| Lee Philina | Chief Commercial Officer | D To issuer | 2025-07-17 | 2025-07-21 | 50,165 | — | $0 | 13,184 | SEC↗ |
| Durso-Bumpus Debra | Chief People Officer | U Tender | 2025-07-17 | 2025-07-21 | 19,856 | — | $0 | 0 | SEC↗ |
| Durso-Bumpus Debra | Chief People Officer | A Award | 2025-07-17 | 2025-07-21 | 21,353 | — | $0 | 70,959 | SEC↗ |
| Durso-Bumpus Debra | Chief People Officer | D To issuer | 2025-07-17 | 2025-07-21 | 51,103 | — | $0 | 19,856 | SEC↗ |
| McCain Tracey L | EVP & Chief Legal Officer | D To issuer | 2025-07-17 | 2025-07-21 | 51,103 | — | $0 | 37,092 | SEC↗ |
| McCain Tracey L | EVP & Chief Legal Officer | A Award | 2025-07-17 | 2025-07-21 | 21,353 | — | $0 | 88,195 | SEC↗ |
| McCain Tracey L | EVP & Chief Legal Officer | U Tender | 2025-07-17 | 2025-07-21 | 37,092 | — | $0 | 0 | SEC↗ |
| Beckman Daniella | Director | U Tender | 2025-07-17 | 2025-07-21 | 10,842 | — | $0 | 0 | SEC↗ |
| Beckman Daniella | Director | D To issuer | 2025-07-17 | 2025-07-21 | 3,902 | — | $0 | 10,842 | SEC↗ |
| Namouni Fouad | PRESIDENT, R & D | U Tender | 2025-07-17 | 2025-07-21 | 31,956 | — | $0 | 0 | SEC↗ |
| Namouni Fouad | PRESIDENT, R & D | A Award | 2025-07-17 | 2025-07-21 | 39,456 | — | $0 | 115,237 | SEC↗ |
| Namouni Fouad | PRESIDENT, R & D | D To issuer | 2025-07-17 | 2025-07-21 | 83,281 | — | $0 | 31,956 | SEC↗ |
| Goldberg Mark Alan | Director | D To issuer | 2025-07-17 | 2025-07-21 | 3,902 | — | $0 | 18,254 | SEC↗ |
| Goldberg Mark Alan | Director | U Tender | 2025-07-17 | 2025-07-21 | 18,254 | — | $0 | 0 | SEC↗ |
| Borisy Alexis | Director | U Tender | 2025-07-17 | 2025-07-21 | 74,160 | — | $0 | 0 | SEC↗ |
| Borisy Alexis | Director | D To issuer | 2025-07-17 | 2025-07-21 | 3,902 | — | $0 | 74,160 | SEC↗ |
| Haviland Kate | Chief Executive Officer | D To issuer | 2025-07-17 | 2025-07-21 | 224,410 | — | $0 | 70,729 | SEC↗ |
| Haviland Kate | Chief Executive Officer | U Tender | 2025-07-17 | 2025-07-21 | 70,729 | — | $0 | 0 | SEC↗ |
| Haviland Kate | Chief Executive Officer | A Award | 2025-07-17 | 2025-07-21 | 129,210 | — | $0 | 295,139 | SEC↗ |
| Rossi Christina | Chief Operating Officer | A Award | 2025-07-17 | 2025-07-21 | 39,456 | — | $0 | 103,002 | SEC↗ |
| Rossi Christina | Chief Operating Officer | D To issuer | 2025-07-17 | 2025-07-21 | 82,374 | — | $0 | 20,628 | SEC↗ |
| Rossi Christina | Chief Operating Officer | U Tender | 2025-07-17 | 2025-07-21 | 20,628 | — | $0 | 0 | SEC↗ |
| Carter Percy H. | Chief Scientific Officer | A Award | 2025-07-17 | 2025-07-21 | 21,353 | — | $0 | 74,508 | SEC↗ |
| Carter Percy H. | Chief Scientific Officer | U Tender | 2025-07-17 | 2025-07-21 | 17,894 | — | $0 | 0 | SEC↗ |
| Carter Percy H. | Chief Scientific Officer | D To issuer | 2025-07-17 | 2025-07-21 | 56,614 | — | $0 | 17,894 | SEC↗ |
| Seely Lynn | Director | U Tender | 2025-07-17 | 2025-07-21 | 13,254 | — | $0 | 0 | SEC↗ |
| Seely Lynn | Director | D To issuer | 2025-07-17 | 2025-07-21 | 3,902 | — | $0 | 13,254 | SEC↗ |
| Hewes L. Becker | Chief Medical Officer | D To issuer | 2025-07-17 | 2025-07-21 | 50,165 | — | $0 | 1,607 | SEC↗ |
| Hewes L. Becker | Chief Medical Officer | A Award | 2025-07-17 | 2025-07-21 | 21,353 | — | $0 | 51,772 | SEC↗ |
| Hewes L. Becker | Chief Medical Officer | U Tender | 2025-07-17 | 2025-07-21 | 1,607 | — | $0 | 0 | SEC↗ |
| COATS LONNEL | Director | D To issuer | 2025-07-17 | 2025-07-21 | 6,144 | — | $0 | 0 | SEC↗ |
| Tsai John | Director | D To issuer | 2025-07-17 | 2025-07-21 | 3,902 | — | $0 | 8,742 | SEC↗ |
| Tsai John | Director | U Tender | 2025-07-17 | 2025-07-21 | 8,742 | — | $0 | 0 | SEC↗ |
| Hurley Ariel | Principal Accounting Officer | A Award | 2025-07-17 | 2025-07-21 | 2,460 | — | $0 | 19,524 | SEC↗ |
| Hurley Ariel | Principal Accounting Officer | U Tender | 2025-07-17 | 2025-07-21 | 3,378 | — | $0 | 0 | SEC↗ |
| Hurley Ariel | Principal Accounting Officer | D To issuer | 2025-07-17 | 2025-07-21 | 16,146 | — | $0 | 3,378 | SEC↗ |
| Dable Habib J | Director | U Tender | 2025-07-17 | 2025-07-21 | 8,742 | — | $0 | 0 | SEC↗ |
| Dable Habib J | Director | D To issuer | 2025-07-17 | 2025-07-21 | 3,902 | — | $0 | 8,742 | SEC↗ |
| Landsittel Michael | Chief Financial Officer | U Tender | 2025-07-17 | 2025-07-21 | 43,175 | — | $0 | 0 | SEC↗ |
| Landsittel Michael | Chief Financial Officer | A Award | 2025-07-17 | 2025-07-21 | 21,353 | — | $0 | 94,277 | SEC↗ |
| Landsittel Michael | Chief Financial Officer | D To issuer | 2025-07-17 | 2025-07-21 | 51,102 | — | $0 | 43,175 | SEC↗ |
| Carter Percy H. | CHIEF SCIENTIFIC OFFICER | S Sale | 2025-07-03 | 2025-07-08 | 1,051 | $128.25 | $134.8K | 53,155 | SEC↗ |
| Rossi Christina | CHIEF OPERATING OFFICER | S Sale | 2025-07-03 | 2025-07-08 | 1,172 | $128.25 | $150.3K | 63,546 | SEC↗ |
| Tsai John | Director | A Award | 2025-06-18 | 2025-06-24 | 3,902 | $128.12 | $499.9K | 12,644 | SEC↗ |
| COATS LONNEL | Director | A Award | 2025-06-18 | 2025-06-24 | 3,902 | $12812.00 | $49.99M | 6,144 | SEC↗ |
| Dable Habib J | Director | A Award | 2025-06-18 | 2025-06-24 | 3,902 | $128.12 | $499.9K | 12,644 | SEC↗ |
| Borisy Alexis | Director | A Award | 2025-06-18 | 2025-06-24 | 3,902 | $128.12 | $499.9K | 78,062 | SEC↗ |
| Beckman Daniella | Director | A Award | 2025-06-18 | 2025-06-24 | 3,902 | $128.12 | $499.9K | 14,744 | SEC↗ |
| Seely Lynn | Director | A Award | 2025-06-18 | 2025-06-24 | 3,902 | $128.12 | $499.9K | 17,156 | SEC↗ |
| Goldberg Mark Alan | Director | A Award | 2025-06-18 | 2025-06-24 | 3,902 | $128.12 | $499.9K | 22,156 | SEC↗ |
| Albers Jeffrey W. | Director | A Award | 2025-06-18 | 2025-06-24 | 3,902 | $128.12 | $499.9K | 150,532 | SEC↗ |
| Carter Percy H. | CHIEF SCIENTIFIC OFFICER | S Sale | 2025-06-03 | 2025-06-05 | 2,418 | $127.88 | $309.2K | 54,206 | SEC↗ |
| Carter Percy H. | CHIEF SCIENTIFIC OFFICER | S Sale | 2025-06-03 | 2025-06-05 | 241 | $127.88 | $30.8K | 56,624 | SEC↗ |
| Albers Jeffrey W. | Director | M Exercise deriv | 2025-05-27 | 2025-05-29 | 5,000 | — | $0 | 92,500 | SEC↗ |
| Albers Jeffrey W. | Director | M Exercise | 2025-05-27 | 2025-05-29 | 5,000 | $36.05 | $180.3K | 151,630 | SEC↗ |
| Albers Jeffrey W. | Director | S Sale | 2025-05-27 | 2025-05-29 | 650 | $101.93 | $66.3K | 146,630 | SEC↗ |
| Albers Jeffrey W. | Director | S Sale | 2025-05-27 | 2025-05-29 | 4,350 | $101.02 | $439.4K | 147,280 | SEC↗ |
| Rossi Christina | CHIEF OPERATING OFFICER | S Sale | 2025-05-19 | 2025-05-21 | 1,413 | $100.67 | $142.2K | 64,775 | SEC↗ |
| Rossi Christina | CHIEF OPERATING OFFICER | S Sale | 2025-05-19 | 2025-05-21 | 57 | $101.72 | $5.8K | 64,718 | SEC↗ |
| Rossi Christina | CHIEF OPERATING OFFICER | S Sale | 2025-05-19 | 2025-05-21 | 804 | $100.14 | $80.5K | 66,188 | SEC↗ |
| Hurley Ariel | PRINCIPAL ACCOUNTING OFFICER | M Exercise deriv | 2025-05-05 | 2025-05-07 | 2,752 | — | $0 | 2,751 | SEC↗ |
| Hurley Ariel | PRINCIPAL ACCOUNTING OFFICER | S Sale | 2025-05-05 | 2025-05-07 | 100 | $104.78 | $10.5K | 16,944 | SEC↗ |
| Hurley Ariel | PRINCIPAL ACCOUNTING OFFICER | S Sale | 2025-05-05 | 2025-05-07 | 1,400 | $103.57 | $145.0K | 17,044 | SEC↗ |
| Hurley Ariel | PRINCIPAL ACCOUNTING OFFICER | S Sale | 2025-05-05 | 2025-05-07 | 1,252 | $102.51 | $128.3K | 18,444 | SEC↗ |
| Hurley Ariel | PRINCIPAL ACCOUNTING OFFICER | M Exercise | 2025-05-05 | 2025-05-07 | 2,752 | $54.13 | $149.0K | 19,696 | SEC↗ |
| Rossi Christina | CHIEF OPERATING OFFICER | S Sale | 2025-05-05 | 2025-05-07 | 607 | $100.97 | $61.3K | 68,659 | SEC↗ |
| Rossi Christina | CHIEF OPERATING OFFICER | S Sale | 2025-05-05 | 2025-05-07 | 180 | $102.82 | $18.5K | 67,136 | SEC↗ |
| Rossi Christina | CHIEF OPERATING OFFICER | S Sale | 2025-05-05 | 2025-05-07 | 144 | $103.56 | $14.9K | 66,992 | SEC↗ |
| Rossi Christina | CHIEF OPERATING OFFICER | S Sale | 2025-05-05 | 2025-05-07 | 1,343 | $101.77 | $136.7K | 67,316 | SEC↗ |
| Haviland Kate | CHIEF EXECUTIVE OFFICER | S Sale | 2025-04-01 | 2025-04-03 | 100 | $88.59 | $8.9K | 165,929 | SEC↗ |
| Haviland Kate | CHIEF EXECUTIVE OFFICER | S Sale | 2025-04-01 | 2025-04-03 | 1,200 | $87.34 | $104.8K | 166,029 | SEC↗ |
| Haviland Kate | CHIEF EXECUTIVE OFFICER | S Sale | 2025-04-01 | 2025-04-03 | 598 | $86.14 | $51.5K | 167,229 | SEC↗ |
| Haviland Kate | CHIEF EXECUTIVE OFFICER | S Sale | 2025-04-01 | 2025-04-03 | 600 | $85.47 | $51.3K | 167,827 | SEC↗ |
| Rossi Christina | CHIEF OPERATING OFFICER | S Sale | 2025-03-24 | 2025-03-26 | 2,274 | $95.02 | $216.1K | 69,266 | SEC↗ |
| Albers Jeffrey W. | Director | M Exercise deriv | 2025-03-12 | 2025-03-14 | 7,500 | — | $0 | 97,500 | SEC↗ |
| Albers Jeffrey W. | Director | S Sale | 2025-03-12 | 2025-03-14 | 1,800 | $88.37 | $159.1K | 152,396 | SEC↗ |
| Albers Jeffrey W. | Director | M Exercise | 2025-03-12 | 2025-03-14 | 7,500 | $36.05 | $270.4K | 159,896 | SEC↗ |
| Albers Jeffrey W. | Director | S Sale | 2025-03-12 | 2025-03-14 | 5,700 | $87.62 | $499.4K | 154,196 | SEC↗ |
| Hewes L. Becker | CHIEF MEDICAL OFFICER | S Sale | 2025-03-06 | 2025-03-07 | 2,691 | $87.42 | $235.2K | 32,960 | SEC↗ |
| Hewes L. Becker | CHIEF MEDICAL OFFICER | S Sale | 2025-03-06 | 2025-03-07 | 2,541 | $87.98 | $223.6K | 30,419 | SEC↗ |
| Carter Percy H. | CHIEF SCIENTIFIC OFFICER | S Sale | 2025-03-05 | 2025-03-07 | 3,530 | $88.80 | $313.5K | 56,865 | SEC↗ |
| Durso-Bumpus Debra | CHIEF PEOPLE OFFICER | S Sale | 2025-03-05 | 2025-03-07 | 5,157 | $88.80 | $457.9K | 49,606 | SEC↗ |
| Haviland Kate | CHIEF EXECUTIVE OFFICER | S Sale | 2025-03-05 | 2025-03-07 | 16,151 | $88.80 | $1.43M | 168,427 | SEC↗ |
| Hurley Ariel | PRINCIPAL ACCOUNTING OFFICER | S Sale | 2025-03-05 | 2025-03-07 | 1,326 | $88.80 | $117.7K | 16,944 | SEC↗ |
| Landsittel Michael | CHIEF FINANCIAL OFFICER | S Sale | 2025-03-05 | 2025-03-07 | 5,284 | $88.80 | $469.2K | 72,924 | SEC↗ |
| Lee Philina | CHIEF COMMERCIAL OFFICER | S Sale | 2025-03-05 | 2025-03-07 | 3,733 | $88.80 | $331.5K | 41,996 | SEC↗ |
| McCain Tracey L | EVP AND CHIEF LEGAL OFFICER | S Sale | 2025-03-05 | 2025-03-07 | 5,262 | $88.80 | $467.3K | 66,583 | SEC↗ |
| Namouni Fouad | PRESIDENT, R & D | S Sale | 2025-03-05 | 2025-03-07 | 6,489 | $88.80 | $576.2K | 75,781 | SEC↗ |
| Rossi Christina | CHIEF OPERATING OFFICER | S Sale | 2025-03-05 | 2025-03-07 | 6,495 | $88.80 | $576.8K | 71,540 | SEC↗ |
| Hewes L. Becker | CHIEF MEDICAL OFFICER | S Sale | 2025-03-05 | 2025-03-07 | 4,863 | $88.80 | $431.8K | 35,651 | SEC↗ |
| Albers Jeffrey W. | Director | S Sale | 2025-03-05 | 2025-03-17 | 5,766 | $88.80 | $512.0K | 146,630 | SEC↗ |
| Hurley Ariel | PRINCIPAL ACCOUNTING OFFICER | S Sale | 2025-03-03 | 2025-03-04 | 1,075 | $95.16 | $102.3K | 18,270 | SEC↗ |
| Hurley Ariel | PRINCIPAL ACCOUNTING OFFICER | S Sale | 2025-03-03 | 2025-03-04 | 775 | $89.63 | $69.5K | 20,698 | SEC↗ |
| Hurley Ariel | PRINCIPAL ACCOUNTING OFFICER | S Sale | 2025-03-03 | 2025-03-04 | 238 | $90.92 | $21.6K | 20,460 | SEC↗ |
| Hurley Ariel | PRINCIPAL ACCOUNTING OFFICER | S Sale | 2025-03-03 | 2025-03-04 | 631 | $92.00 | $58.1K | 19,829 | SEC↗ |
| Hurley Ariel | PRINCIPAL ACCOUNTING OFFICER | S Sale | 2025-03-03 | 2025-03-04 | 484 | $93.42 | $45.2K | 19,345 | SEC↗ |
| Durso-Bumpus Debra | CHIEF PEOPLE OFFICER | A Award deriv | 2025-03-01 | 2025-03-04 | 22,000 | — | $0 | 22,000 | SEC↗ |
| Namouni Fouad | PRESIDENT, R & D | A Award deriv | 2025-03-01 | 2025-03-04 | 26,400 | — | $0 | 26,400 | SEC↗ |
| Landsittel Michael | CHIEF FINANCIAL OFFICER | A Award deriv | 2025-03-01 | 2025-03-04 | 22,000 | — | $0 | 22,000 | SEC↗ |
| Carter Percy H. | CHIEF SCIENTIFIC OFFICER | A Award deriv | 2025-03-01 | 2025-03-04 | 22,000 | — | $0 | 22,000 | SEC↗ |
| Rossi Christina | CHIEF OPERATING OFFICER | A Award deriv | 2025-03-01 | 2025-03-04 | 26,400 | — | $0 | 26,400 | SEC↗ |
| Haviland Kate | CHIEF EXECUTIVE OFFICER | A Award deriv | 2025-03-01 | 2025-03-04 | 70,400 | — | $0 | 70,400 | SEC↗ |
| McCain Tracey L | EVP AND CHIEF LEGAL OFFICER | A Award deriv | 2025-03-01 | 2025-03-04 | 22,000 | — | $0 | 22,000 | SEC↗ |
| Hurley Ariel | PRINCIPAL ACCOUNTING OFFICER | A Award deriv | 2025-03-01 | 2025-03-04 | 7,007 | $95.67 | $670.4K | 7,007 | SEC↗ |
| Lee Philina | CHIEF COMMERCIAL OFFICER | A Award deriv | 2025-03-01 | 2025-03-04 | 22,000 | — | $0 | 22,000 | SEC↗ |
| Hewes L. Becker | CHIEF MEDICAL OFFICER | A Award deriv | 2025-03-01 | 2025-03-04 | 22,000 | — | $0 | 22,000 | SEC↗ |
| Durso-Bumpus Debra | CHIEF PEOPLE OFFICER | A Award | 2025-03-01 | 2025-03-04 | 11,000 | — | $0 | 54,763 | SEC↗ |
| Namouni Fouad | PRESIDENT, R & D | A Award | 2025-03-01 | 2025-03-04 | 13,200 | — | $0 | 82,270 | SEC↗ |
| Landsittel Michael | CHIEF FINANCIAL OFFICER | A Award | 2025-03-01 | 2025-03-04 | 11,000 | — | $0 | 78,208 | SEC↗ |
| Carter Percy H. | CHIEF SCIENTIFIC OFFICER | A Award | 2025-03-01 | 2025-03-04 | 11,000 | — | $0 | 60,395 | SEC↗ |
| Rossi Christina | CHIEF OPERATING OFFICER | A Award | 2025-03-01 | 2025-03-04 | 13,200 | — | $0 | 78,035 | SEC↗ |
| Haviland Kate | CHIEF EXECUTIVE OFFICER | A Award | 2025-03-01 | 2025-03-04 | 35,200 | — | $0 | 184,578 | SEC↗ |
| McCain Tracey L | EVP AND CHIEF LEGAL OFFICER | A Award | 2025-03-01 | 2025-03-04 | 11,000 | — | $0 | 71,845 | SEC↗ |
| Hurley Ariel | PRINCIPAL ACCOUNTING OFFICER | A Award | 2025-03-01 | 2025-03-04 | 6,506 | — | $0 | 21,473 | SEC↗ |
| Lee Philina | CHIEF COMMERCIAL OFFICER | A Award | 2025-03-01 | 2025-03-04 | 11,000 | — | $0 | 45,729 | SEC↗ |
| Hewes L. Becker | CHIEF MEDICAL OFFICER | A Award | 2025-03-01 | 2025-03-04 | 11,000 | — | $0 | 40,514 | SEC↗ |
| Rossi Christina | CHIEF OPERATING OFFICER | S Sale | 2025-02-20 | 2025-02-24 | 2,274 | $95.14 | $216.3K | 64,835 | SEC↗ |
| Albers Jeffrey W. | Director | M Exercise deriv | 2025-01-21 | 2025-01-23 | 10,000 | — | $0 | 105,000 | SEC↗ |
| Albers Jeffrey W. | Director | S Sale | 2025-01-21 | 2025-01-23 | 200 | $110.61 | $22.1K | 152,396 | SEC↗ |
| Albers Jeffrey W. | Director | S Sale | 2025-01-21 | 2025-01-23 | 7,400 | $109.92 | $813.4K | 152,596 | SEC↗ |
| Albers Jeffrey W. | Director | S Sale | 2025-01-21 | 2025-01-23 | 7,561 | $109.11 | $825.0K | 159,996 | SEC↗ |
| Albers Jeffrey W. | Director | M Exercise | 2025-01-21 | 2025-01-23 | 10,000 | $36.05 | $360.5K | 167,557 | SEC↗ |
| Rossi Christina | CHIEF OPERATING OFFICER | S Sale | 2025-01-21 | 2025-01-23 | 529 | $108.99 | $57.7K | 68,854 | SEC↗ |
| Rossi Christina | CHIEF OPERATING OFFICER | S Sale | 2025-01-21 | 2025-01-23 | 816 | $110.00 | $89.8K | 68,038 | SEC↗ |
| Rossi Christina | CHIEF OPERATING OFFICER | S Sale | 2025-01-21 | 2025-01-23 | 808 | $110.78 | $89.5K | 67,230 | SEC↗ |
| Rossi Christina | CHIEF OPERATING OFFICER | S Sale | 2025-01-21 | 2025-01-23 | 121 | $111.81 | $13.5K | 67,109 | SEC↗ |
| Haviland Kate | CHIEF EXECUTIVE OFFICER | S Sale | 2025-01-21 | 2025-01-23 | 1,446 | $110.24 | $159.4K | 149,378 | SEC↗ |
| Hurley Ariel | PRINCIPAL ACCOUNTING OFFICER | M Exercise deriv | 2025-01-13 | 2025-01-15 | 2,250 | — | $0 | 2,250 | SEC↗ |
| Albers Jeffrey W. | Director | M Exercise deriv | 2025-01-13 | 2025-01-15 | 5,000 | — | $0 | 115,000 | SEC↗ |
| Hurley Ariel | PRINCIPAL ACCOUNTING OFFICER | M Exercise | 2025-01-13 | 2025-01-15 | 2,250 | $36.05 | $81.1K | 17,217 | SEC↗ |
| Hurley Ariel | PRINCIPAL ACCOUNTING OFFICER | S Sale | 2025-01-13 | 2025-01-15 | 2,250 | $100.00 | $225.0K | 14,967 | SEC↗ |
| Albers Jeffrey W. | Director | M Exercise | 2025-01-13 | 2025-01-15 | 5,000 | $36.05 | $180.3K | 162,557 | SEC↗ |
| Albers Jeffrey W. | Director | S Sale | 2025-01-13 | 2025-01-15 | 5,000 | $102.28 | $511.4K | 157,557 | SEC↗ |
| Albers Jeffrey W. | Director | M Exercise deriv | 2024-12-19 | 2024-12-20 | 15,000 | $36.05 | $540.8K | 120,000 | SEC↗ |
| Albers Jeffrey W. | Director | M Exercise | 2024-12-19 | 2024-12-20 | 15,000 | $36.05 | $540.8K | 172,557 | SEC↗ |
| Albers Jeffrey W. | Director | S Sale | 2024-12-19 | 2024-12-20 | 3,920 | $88.28 | $346.1K | 168,637 | SEC↗ |
| Albers Jeffrey W. | Director | S Sale | 2024-12-19 | 2024-12-20 | 5,180 | $89.01 | $461.1K | 163,457 | SEC↗ |
| Albers Jeffrey W. | Director | S Sale | 2024-12-19 | 2024-12-20 | 3,800 | $91.15 | $346.4K | 159,657 | SEC↗ |
| Albers Jeffrey W. | Director | S Sale | 2024-12-19 | 2024-12-20 | 2,100 | $91.96 | $193.1K | 157,557 | SEC↗ |
| Rossi Christina | CHIEF OPERATING OFFICER | S Sale | 2024-12-18 | 2024-12-20 | 2,166 | $95.88 | $207.7K | 69,491 | SEC↗ |
| Rossi Christina | CHIEF OPERATING OFFICER | S Sale | 2024-12-18 | 2024-12-20 | 108 | $96.50 | $10.4K | 69,383 | SEC↗ |
| Hurley Ariel | PRINCIPAL ACCOUNTING OFFICER | M Exercise deriv | 2024-12-12 | 2024-12-16 | 1,600 | $15.01 | $24.0K | 0 | SEC↗ |
| Hurley Ariel | PRINCIPAL ACCOUNTING OFFICER | S Sale | 2024-12-12 | 2024-12-16 | 619 | $93.99 | $58.2K | 14,967 | SEC↗ |
| Hurley Ariel | PRINCIPAL ACCOUNTING OFFICER | S Sale | 2024-12-12 | 2024-12-16 | 1,200 | $92.88 | $111.5K | 15,586 | SEC↗ |
| Hurley Ariel | PRINCIPAL ACCOUNTING OFFICER | M Exercise | 2024-12-12 | 2024-12-16 | 1,600 | $15.01 | $24.0K | 16,786 | SEC↗ |
| Haviland Kate | CHIEF EXECUTIVE OFFICER | S Sale | 2024-11-29 | 2024-12-03 | 400 | $95.40 | $38.2K | 152,777 | SEC↗ |
| Haviland Kate | CHIEF EXECUTIVE OFFICER | S Sale | 2024-11-29 | 2024-12-03 | 1,746 | $96.74 | $168.9K | 151,031 | SEC↗ |
| Haviland Kate | CHIEF EXECUTIVE OFFICER | S Sale | 2024-11-29 | 2024-12-03 | 207 | $97.76 | $20.2K | 150,824 | SEC↗ |
| Rossi Christina | CHIEF OPERATING OFFICER | S Sale | 2024-11-27 | 2024-12-02 | 2,274 | $95.10 | $216.3K | 71,657 | SEC↗ |
| COATS LONNEL | Director | S Sale | 2024-11-21 | 2024-11-22 | 9,824 | $94.87 | $932.0K | 2,242 | SEC↗ |
| COATS LONNEL | Director | M Exercise deriv | 2024-11-20 | 2024-11-22 | 1,312 | — | $0 | 3,188 | SEC↗ |
| COATS LONNEL | Director | M Exercise deriv | 2024-11-20 | 2024-11-22 | 7,500 | — | $0 | 0 | SEC↗ |
| COATS LONNEL | Director | S Sale | 2024-11-20 | 2024-11-22 | 4,500 | $93.15 | $419.2K | 17,566 | SEC↗ |
| COATS LONNEL | Director | S Sale | 2024-11-20 | 2024-11-22 | 213 | $94.99 | $20.2K | 12,066 | SEC↗ |
| COATS LONNEL | Director | S Sale | 2024-11-20 | 2024-11-22 | 5,287 | $94.24 | $498.2K | 12,279 | SEC↗ |
| COATS LONNEL | Director | M Exercise | 2024-11-20 | 2024-11-22 | 1,312 | $76.24 | $100.0K | 22,066 | SEC↗ |
| COATS LONNEL | Director | M Exercise | 2024-11-20 | 2024-11-22 | 7,500 | $69.79 | $523.4K | 20,754 | SEC↗ |
| Albers Jeffrey W. | Director | M Exercise deriv | 2024-11-07 | 2024-11-12 | 5,000 | — | $0 | 135,000 | SEC↗ |
| Albers Jeffrey W. | Director | M Exercise | 2024-11-07 | 2024-11-12 | 5,000 | $36.05 | $180.3K | 162,557 | SEC↗ |
| Albers Jeffrey W. | Director | S Sale | 2024-11-07 | 2024-11-12 | 5,000 | $102.00 | $510.0K | 157,557 | SEC↗ |
| Namouni Fouad | PRESIDENT, R & D | S Sale | 2024-10-03 | 2024-10-04 | 3,633 | $89.32 | $324.5K | 69,070 | SEC↗ |
| Albers Jeffrey W. | Director | M Exercise deriv | 2024-09-09 | 2024-09-11 | 10,000 | — | $0 | 140,000 | SEC↗ |
| Albers Jeffrey W. | Director | M Exercise | 2024-09-09 | 2024-09-11 | 10,000 | $36.05 | $360.5K | 177,259 | SEC↗ |
| Albers Jeffrey W. | Director | S Sale | 2024-09-09 | 2024-09-11 | 11,968 | $85.86 | $1.03M | 165,291 | SEC↗ |
| Albers Jeffrey W. | Director | S Sale | 2024-09-09 | 2024-09-11 | 7,734 | $85.12 | $658.3K | 157,557 | SEC↗ |
| Landsittel Michael | CHIEF FINANCIAL OFFICER | S Sale | 2024-08-15 | 2024-08-19 | 4,409 | $95.23 | $419.9K | 67,208 | SEC↗ |
| Lee Philina | CHIEF COMMERCIAL OFFICER | M Exercise deriv | 2024-08-05 | 2024-08-07 | 12,350 | — | $0 | 0 | SEC↗ |
| Lee Philina | CHIEF COMMERCIAL OFFICER | M Exercise deriv | 2024-08-05 | 2024-08-07 | 10,572 | — | $0 | 6,928 | SEC↗ |